FDA Finds Multiple Faults at Second-Biggest Indian Drugmaker
US Food and Drug Administration officials found multiple faults at a plant run by one of India’s biggest
2023-06-30 18:21
Last Taboo for Hit Obesity Drug Is Asking When to Stop
Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question
2023-06-30 12:29
Ex-Pfizer Employee Charged With Illegal Trades on Paxlovid Trial
A former Pfizer Inc. employee was charged with using inside information about the company’s Covid-19 treatment Paxlovid to
2023-06-30 02:23
Dealmakers Adrift as $1 Trillion Vanishes in First-Half
The world’s dealmakers are roughly $1 trillion down in one of the worst years for takeovers and stock
2023-06-29 16:46
Ipsen Gets FDA Advisers’ Backing for Rare Bone Disease Drug
Ipsen SA’s drug for a rare bone disease got support from a panel of US drug regulatory advisers,
2023-06-29 15:25
Pfizer’s Exit Halves Japan Biotech Firm Value In Just Three Days
Sosei Group Corp. has lost over half of its market value in just three days on concern about
2023-06-29 11:49
Walgreens Falls as Outlook Slashed on Fading Pandemic Demand
Walgreens Boots Alliance Inc. shares tumbled after the drugstore chain slashed its adjusted earnings forecast for the fiscal
2023-06-27 21:25
Asian Stocks Fluctuate Amid Recession Fears: Markets Wrap
Asian shares were mixed Tuesday after US stocks fell amid concern that the Federal Reserve and its peers
2023-06-27 08:46
Asia Shares Outlook Look Mixed Amid Recession Fear: Markets Wrap
Asian shares are poised for a mixed open Tuesday after US stocks fell amid concern that the Federal
2023-06-27 06:53
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:22
Pfizer Drops as Obesity Drug Halted on Safety Concerns
Pfizer Inc. shares fell after it halted early development of an oral drug for weight loss on safety
2023-06-27 01:45
Japan Unveils $6 Billion Deal to Buy Out Chip Linchpin JSR
Japan’s government unveiled a $6.3 billion deal to buy out and privatize JSR Corp., taking direct control of
2023-06-26 19:16